Литература. 
Новые подходы в определении и классификации кардиомиопатий

1. Bowles K., Gajarski R., Porter P. et al. Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21−23 // J. Clin. Invest. 1996. Vol. 98. P. 1355−1360.

2. Bridgen W. Uncommon myocardial diseases — the noncoronary cardiomyopathies // Lancet. 1957. Vol. 2. P. 1243−1249.

3. Cooper L.T., Baughman K.L., Feldman A.M. et al. The Role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology // J. Amer. Coll. Cardiology. 2007. Vol. 50. P. 1914;1931.

4. Elliott P., Andersson B., Arbustini E. et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases // Eur. Heart. J. 2008. Vol. 29, № 2. P. 270−276.

5. Keeling PJ., Gang G., Smith G. et al. Familial dilated cardiomyopathy in the United Kingdom // Brit. Heart. J. 1995. Vol. 73. P. 417−421.

6. Maron B.J., Towbin J.A., Thiene G. et al. American Heart Association; Councilon Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention // Circulation. 2006. Vol. 113. P.1807−1816.

7. Mestroni L. Dilated cardiomyopathy: a genetic approach // Heart. 1997. Vol. 77. P. 185−188.

8. Mestroni L., Maisch B., McKenna W. et al. Guidelines for the study of familial dilated cardiomyopathies // Eur. Heart J. 1999. Vol. 20. P. 93−102.

9. Norgett E.E., Hatsell S.J., Carvajal-Huerta L. et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma // Hum. Mol. Genet. 2000. Vol. 9, № 18. P. 2761−2766.

10. Priori S., Napolitano C., Tiso N. et al. Mutations in the cardiacryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachicardia // Circulation. 2001. Vol. 103. P. 196−200.

11. Priori S., Napolitano C. Genetic defects of cardiac ion channels. The hidden substrate for torsades de pointes // Cardiovasc. Drugs. Ther. 2002. Vol. 16. P. 89−92.

12. Priori S., Schwartz P., Napolitano C. et al. Risk stratification in the long-QT syndrome // New Engl. J. Med. 2003. Vol. 348. P.1866−1874.

13. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies // Brit. Heart J. 1980. Vol. 44. P. 672−673.

14. Richardson D., McKenna W., Bristow M. et al. WHO/ISFC Task Force definition and classification of cardiomyopathies // Circulation. 1996. Vol. 93. P. 841−842.

15. Thiene G., Corrado D., Basso C. Cardiomyopathies: is it time for a molecular classification? // Eur. Heart J. 2004. Vol. 25. P. 1772−1775.

16. Towbin J., Hejtmancik F., Brink P. et al. X-linked dilated cardiomyopathy molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus // Circulation. 1993. Vol. 87. P. 1854−1865.

17. Towbin J.A., Bowles N.E. Genetic abnormalities responsible for dilated cardiomyopathy // Curr. Cardiol. Rep. 2000. Vol. 2. P. 475−480.